A possible role for saliva as a diagnostic fluid in patients with chronic pain

被引:42
作者
Fischer, HP
Eich, W
Russell, IJ
机构
[1] Heidelberg Univ, Med Klin & Poliklin, D-69115 Heidelberg, Germany
[2] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
[3] Heidelberg Univ, Rheumatol & Psychosomat Outpatient Dept, D-69115 Heidelberg, Germany
关键词
substance P (SP); calcitonin gene-related peptide (CGRP); nerve growth factor (NGF); serotonin (5HT); saliva; chronic pain; fibromyalgia syndrome (FMS);
D O I
10.1016/S0049-0172(98)80014-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The focus of this review was on proteins and peptides found in saliva. Of greatest interest were those neuropeptides relevant to nociception and to the pathogenesis of chronic pain syndromes. An additional goal wits to develop a standardized protocol to collect saliva for laboratory assessment. Methods: Data were obtained through discussion with experts at the medical schools in San Antonio and Heidelberg and a Medline literature search involving all relevant studies from 1966 to 1997, The literature search was based on the following key terms: saliva, serotonin, neuropeptide, substance P (SP), calcitonin gene-related peptide (CGRP), and nerve growth factor (NGF). Results: The mean concentration of SP in the saliva of healthy normal controls ranged from 9.6 to 220 pg/mL. Generally, the concentration of SP was approximately three times higher in saliva than in plasma, In a number of painful conditions, particularly tension headache, substantial elevations of salivary SP were found. Mean values for salivary CGRP in healthy controls were approximately 22 pmol/L and were significantly elevated in patients with migraine attacks or cluster headache. There were no data to indicate prior quantitative determination of NGF in human saliva. Conclusions: After sampling and processing techniques have been standardized, measurement of neuropeptides in human saliva could provide a valuable tool for the study of patients with chronic painful disorders such as rheumatoid arthritis, osteoarthritis, and even fibromyalgia syndrome. Copyright (C) 1998 by W.B. Saunders Company.
引用
收藏
页码:348 / 359
页数:12
相关论文
共 152 条
[31]   INCREASED FREQUENCY OF NGF IN SERA OF RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS [J].
DICOU, E ;
MASSON, C ;
JABBOUR, W ;
NERRIERE, V .
NEUROREPORT, 1993, 5 (03) :321-324
[32]   Evidence that natural autoantibodies against the nerve growth factor (NGF) may be potential carriers of NGF [J].
Dicou, E ;
Nerriere, V .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 75 (1-2) :200-203
[33]   THERAPEUTIC DRUG-MONITORING IN SALIVA - AN UPDATE [J].
DROBITCH, RK ;
SVENSSON, CK .
CLINICAL PHARMACOKINETICS, 1992, 23 (05) :365-379
[34]   Nitric oxide and release of the peptide vip from parasympathetic terminals in the submandibular gland of the anaesthetized cat [J].
Edwards, AV ;
Tobin, G ;
Ekstrom, J ;
Bloom, SR .
EXPERIMENTAL PHYSIOLOGY, 1996, 81 (03) :349-359
[35]   Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis [J].
Falcini, F ;
Cerinic, MM ;
Lombardi, A ;
Generini, S ;
Pignone, A ;
Tirassa, P ;
Ermini, M ;
Lepore, L ;
Partsch, G ;
Aloe, L .
ANNALS OF THE RHEUMATIC DISEASES, 1996, 55 (10) :745-748
[36]  
Fallone CA, 1996, AM J GASTROENTEROL, V91, P1145
[37]   IMMUNOHISTOCHEMICAL LOCALIZATION OF ERYTHROPOIETIN IN THE RAT AND MOUSE SUB-MANDIBULAR GLAND [J].
FAVADEMORAES, F ;
ZANGHERI, EO ;
DOINE, AI .
HISTOCHEMICAL JOURNAL, 1979, 11 (01) :97-102
[38]  
Fortier LA, 1997, J RHEUMATOL, V24, P524
[39]   XEROSTOMIA - EVALUATION OF A SYMPTOM WITH INCREASING SIGNIFICANCE [J].
FOX, PC ;
VANDERVEN, PF ;
SONIES, BC ;
WEIFFENBACH, JM ;
BAUM, BJ .
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1985, 110 (04) :519-525
[40]   Detection of human Betaherpesvirinae in saliva and urine from immunocompromised and immunocompetent subjects [J].
GautheretDejean, A ;
Aubin, JT ;
Poirel, L ;
Huraux, JM ;
Nicolas, JC ;
Rozenbaum, W ;
Agut, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (06) :1600-1603